TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

Clinical trial NCT03179904 · COMPLETED

Trial details

NCT number: NCT03179904
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Breast Carcinoma HER2-Positive Breast Carcinoma Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IV Breast Cancer AJCC v8 HER2-positive Breast Cancer

Start date: 2017-08-03
Primary completion: 2024-07-30
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.